Article ID Journal Published Year Pages File Type
8790158 Urologic Oncology: Seminars and Original Investigations 2018 7 Pages PDF
Abstract
Our data suggest that patients who did not receive NAC benefit from an adequate LND. However, the receipt of an adequate LND was not associated with an OS benefit in patients pretreated with NAC. Our study indicates that the receipt of NAC may eradicate micrometastatic disease, and thus limit the benefit of an adequate LND.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , , , , , ,